{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:39:36Z","timestamp":1791362376169,"version":"4.3.1"},"reference-count":179,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.anai.2023.05.010","type":"journal-article","created":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T02:47:38Z","timestamp":1684464458000},"page":"151-169","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Knowledge gaps in the diagnosis and management of anaphylaxis"],"prefix":"10.1016","volume":"131","author":[{"given":"Dana V.","family":"Wallace","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.anai.2023.05.010_bib0001","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jaci.2013.08.016","article-title":"Anaphylaxis in America: the prevalence and characteristics of anaphylaxis in the United States","volume":"133","author":"Wood","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2023.05.010_bib0002","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.jaip.2017.06.031","article-title":"Fatal anaphylaxis: mortality rate and risk factors","volume":"5","author":"Turner","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"12","key":"10.1016\/j.anai.2023.05.010_bib0003","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1111\/cea.13287","article-title":"Food-induced fatal anaphylaxis: from epidemiological data to general prevention strategies","volume":"48","author":"Pouessel","year":"2018","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.anai.2023.05.010_bib0004","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.resuscitation.2021.04.010","article-title":"Evidence update for the treatment of anaphylaxis","volume":"163","author":"Dodd","year":"2021","journal-title":"Resuscitation"},{"issue":"1","key":"10.1016\/j.anai.2023.05.010_bib0005","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.iac.2021.10.002","article-title":"Anaphylaxis: data gaps and research needs","volume":"42","author":"Dribin","year":"2022","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.anai.2023.05.010_bib0006","unstructured":"Golden D, Wang J. Anaphylaxis Traditional PP Update. 2023."},{"issue":"3","key":"10.1016\/j.anai.2023.05.010_bib0007","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.jaci.2021.07.035","article-title":"Anaphylaxis knowledge gaps and future research priorities: a consensus report","volume":"149","author":"Dribin","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2023.05.010_bib0008","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/all.15032","article-title":"EAACI guidelines: anaphylaxis (2021 update)","volume":"77","author":"Muraro","year":"2022","journal-title":"Allergy"},{"issue":"10","key":"10.1016\/j.anai.2023.05.010_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2020.100472","article-title":"World allergy organization anaphylaxis guidance 2020","volume":"13","author":"Cardona","year":"2020","journal-title":"World Allergy Organ J"},{"issue":"3","key":"10.1016\/j.anai.2023.05.010_bib0010","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/XEB.0000000000000054","article-title":"Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data","volume":"13","author":"Munn","year":"2015","journal-title":"Int J Evid-Based Healthc"},{"issue":"31","key":"10.1016\/j.anai.2023.05.010_bib0011","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.1016\/j.vaccine.2007.02.064","article-title":"Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data","volume":"25","author":"Ruggeberg","year":"2007","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.anai.2023.05.010_bib0012","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1016\/j.jaip.2021.04.025","article-title":"Ascertainment bias in anaphylaxis safety data of COVID-19 vaccines","volume":"9","author":"Hourihane","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"15","key":"10.1016\/j.anai.2023.05.010_bib0013","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1016\/j.vaccine.2022.11.027","article-title":"Anaphylaxis: revision of the Brighton collaboration case definition","volume":"41","author":"Gold","year":"2023","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.anai.2023.05.010_bib0014","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jaci.2005.12.1303","article-title":"Second symposium on the definition and management of anaphylaxis: summary report\u2013Second National Institute of Allergy and Infectious Disease\/Food Allergy and Anaphylaxis Network symposium","volume":"117","author":"Sampson","year":"2006","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2023.05.010_bib0015","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.jaip.2018.10.052","article-title":"Guiding principles for the recognition, diagnosis, and management of infants with anaphylaxis: an expert panel consensus","volume":"7","author":"Greenhawt","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.anai.2023.05.010_bib0016","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jpeds.2010.10.017","article-title":"Age-related differences in the clinical presentation of food-induced anaphylaxis","volume":"158","author":"Rudders","year":"2011","journal-title":"J Pediatr"},{"issue":"3","key":"10.1016\/j.anai.2023.05.010_bib0017","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.anai.2018.05.025","article-title":"Food-induced anaphylaxis in infants and children","volume":"121","author":"Samady","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.05.010_bib0018","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jaip.2020.11.005","article-title":"Caregiver-reported presentation of severe food-induced allergic reactions in infants and toddlers","volume":"9","author":"Pistiner","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.anai.2023.05.010_bib0019","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/EDE.0000000000001330","article-title":"Identification and validation of anaphylaxis using electronic health data in a population-based setting","volume":"32","author":"Bann","year":"2021","journal-title":"Epidemiology"},{"issue":"1 Pt 1","key":"10.1016\/j.anai.2023.05.010_bib0020","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/0091-6749(86)90117-X","article-title":"Biphasic and protracted anaphylaxis","volume":"78","author":"Stark","year":"1986","journal-title":"J Allergy Clin Immunol"},{"issue":"8009","key":"10.1016\/j.anai.2023.05.010_bib0021","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0140-6736(77)91953-5","article-title":"Incidence and severity of anaphylactoid reactions to colloid volume substitutes","volume":"1","author":"Ring","year":"1977","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.anai.2023.05.010_bib0022","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jaci.2009.10.060","article-title":"Speaking the same language: the World Allergy Organization subcutaneous immunotherapy systemic reaction grading system","volume":"125","author":"Cox","year":"2010","journal-title":"J Allergy Clin Immunol"},{"issue":"6 Pt 3","key":"10.1016\/j.anai.2023.05.010_bib0023","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1542\/peds.111.S3.1601","article-title":"Anaphylaxis and emergency treatment","volume":"111","author":"Sampson","year":"2003","journal-title":"Pediatrics"},{"issue":"8","key":"10.1016\/j.anai.2023.05.010_bib0024","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1398-9995.2007.01421.x","article-title":"The management of anaphylaxis in childhood: position paper of the European academy of allergology and clinical immunology","volume":"62","author":"Muraro","year":"2007","journal-title":"Allergy"},{"issue":"9","key":"10.1016\/j.anai.2023.05.010_bib0025","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1111\/all.13408","article-title":"The urgent need for a harmonized severity scoring system for acute allergic reactions","volume":"73","author":"Muraro","year":"2018","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.anai.2023.05.010_bib0026","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jaci.2004.04.029","article-title":"Clinical features and severity grading of anaphylaxis","volume":"114","author":"Brown","year":"2004","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2023.05.010_bib0027","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.jaci.2012.10.017","article-title":"Standardizing double-blind, placebo-controlled oral food challenges: American Academy of Allergy, Asthma & Immunology-European Academy of Allergy and Clinical Immunology PRACTALL consensus report","volume":"130","author":"Sampson","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.05.010_bib0028","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jaip.2016.11.009","article-title":"World Allergy Organization systemic allergic reaction grading system: is a modification needed?","volume":"5","author":"Cox","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.anai.2023.05.010_bib0029","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/all.12765","article-title":"Time for a new grading system for allergic reactions?","volume":"71","author":"Niggemann","year":"2016","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.anai.2023.05.010_bib0030","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1111\/all.15165","article-title":"Development and validation of the food allergy severity score","volume":"77","author":"Fernandez-Rivas","year":"2022","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.anai.2023.05.010_bib0031","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/ACI.0000000000000901","article-title":"Grading the severity of anaphylaxis","volume":"23","author":"Stafford","year":"2023","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2023.05.010_bib0032","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1016\/j.jaci.2021.12.789","article-title":"Updating the CoFAR grading scale for systemic allergic reactions in food allergy","volume":"149","author":"Chinthrajah","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.05.010_bib0033","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jaci.2021.01.003","article-title":"Severity grading system for acute allergic reactions: a multidisciplinary Delphi study","volume":"148","author":"Dribin","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"10.1016\/j.anai.2023.05.010_bib0034","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1016\/j.jaip.2021.06.056","article-title":"Improving severity scoring of food-induced allergic reactions: a global \u201cbest-worst scaling\u201d exercise","volume":"9","author":"Stafford","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"10","key":"10.1016\/j.anai.2023.05.010_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2019.100066","article-title":"Time to revisit the definition and clinical criteria for anaphylaxis?","volume":"12","author":"Turner","year":"2019","journal-title":"World Allergy Organ J"},{"issue":"1","key":"10.1016\/j.anai.2023.05.010_bib0036","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40413-015-0080-1","article-title":"2015 update of the evidence base: World Allergy Organization anaphylaxis guidelines","volume":"8","author":"Simons","year":"2015","journal-title":"World Allergy Organ J"},{"issue":"6","key":"10.1016\/j.anai.2023.05.010_bib0037","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.anai.2014.10.007","article-title":"Emergency department diagnosis and treatment of anaphylaxis: a practice parameter","volume":"113","author":"Campbell","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"10.1016\/j.anai.2023.05.010_bib0038","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.jaip.2019.11.027","article-title":"Global trends in anaphylaxis epidemiology and clinical implications","volume":"8","author":"Turner","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"8","key":"10.1016\/j.anai.2023.05.010_bib0039","doi-asserted-by":"crossref","first-page":"e13892","DOI":"10.2196\/13892","article-title":"Childrens\u2019 and parents\u2019 willingness to join a smartphone-based emergency response community for anaphylaxis: survey","volume":"7","author":"Khalemsky","year":"2019","journal-title":"JMIR Mhealth Uhealth"},{"issue":"8","key":"10.1016\/j.anai.2023.05.010_bib0040","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1016\/j.jaip.2021.03.011","article-title":"Use and interpretation of acute and baseline tryptase in perioperative hypersensitivity and anaphylaxis","volume":"9","author":"Vitte","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2-3","key":"10.1016\/j.anai.2023.05.010_bib0041","first-page":"111","article-title":"Incidence of anaphylaxis in the emergency department: a 1-year study in a university hospital","volume":"24","author":"Poachanukoon","year":"2006","journal-title":"Asian Pac J Allergy Immunol"},{"issue":"12","key":"10.1016\/j.anai.2023.05.010_bib0042","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1111\/all.13226","article-title":"Validation of international consensus equation for acute serum total tryptase in mast cell activation: a perioperative perspective","volume":"72","author":"Baretto","year":"2017","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.anai.2023.05.010_bib0043","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.jaci.2021.08.007","article-title":"Defining baseline variability of serum tryptase levels improves accuracy in identifying anaphylaxis","volume":"149","author":"Mateja","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.05.010_bib0044","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jaip.2022.09.019","article-title":"Anaphylaxis: advances in the past 10 years","volume":"11","author":"Weiler","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"12","key":"10.1016\/j.anai.2023.05.010_bib0045","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1038\/ng.3696","article-title":"Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number","volume":"48","author":"Lyons","year":"2016","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.anai.2023.05.010_bib0046","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jaci.2020.06.035","article-title":"Heritable risk for severe anaphylaxis associated with increased alpha-tryptase-encoding germline copy number at TPSAB1","volume":"147","author":"Lyons","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2023.05.010_bib0047","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1016\/j.jaip.2021.03.005","article-title":"The genetic basis and clinical impact of hereditary alpha-tryptasemia","volume":"9","author":"Luskin","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.anai.2023.05.010_bib0048","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.anai.2021.01.016","article-title":"Hereditary alpha-tryptasemia in 101 patients with mast cell activation-related symptomatology including anaphylaxis","volume":"126","author":"Giannetti","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"8","key":"10.1016\/j.anai.2023.05.010_bib0049","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/j.jaip.2022.05.003","article-title":"Incorporating tryptase genotyping into the workup and diagnosis of mast cell diseases and reactions","volume":"10","author":"Lyons","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"11","key":"10.1016\/j.anai.2023.05.010_bib0050","doi-asserted-by":"crossref","first-page":"e646","DOI":"10.1097\/HS9.0000000000000646","article-title":"Updated diagnostic criteria and classification of mast cell disorders: a consensus proposal","volume":"5","author":"Valent","year":"2021","journal-title":"Hemasphere"},{"issue":"2","key":"10.1016\/j.anai.2023.05.010_bib0051","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jaci.2020.06.008","article-title":"Phenotype and risk factors of venom-induced anaphylaxis: a case-control study of the European Anaphylaxis Registry","volume":"147","author":"Francuzik","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.05.010_bib0052","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.anai.2016.10.031","article-title":"Stinging insect hypersensitivity: a practice parameter update 2016","volume":"118","author":"Golden","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"9","key":"10.1016\/j.anai.2023.05.010_bib0053","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1046\/j.1365-2222.2003.01755.x","article-title":"Elevated basal serum tryptase and hymenoptera venom allergy: relation to severity of sting reactions and to safety and efficacy of venom immunotherapy","volume":"33","author":"Haeberli","year":"2003","journal-title":"Clin Exp Allergy"},{"issue":"7","key":"10.1016\/j.anai.2023.05.010_bib0054","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1398-9995.2009.02302.x","article-title":"Basal serum tryptase as risk assessment for severe Hymenoptera sting reactions in elderly","volume":"65","author":"Guenova","year":"2010","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.anai.2023.05.010_bib0055","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/ACI.0b013e32833b280c","article-title":"Mastocytosis and insect venom allergy","volume":"10","author":"Bonadonna","year":"2010","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2023.05.010_bib0056","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.jaip.2017.03.019","article-title":"Fatal anaphylaxis to yellow jacket stings in mastocytosis: options for identification and treatment of at-risk patients","volume":"5","author":"Vos","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.anai.2023.05.010_bib0057","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.jaip.2022.11.012","article-title":"Perioperative hypersensitivity evaluation and management: a practical approach","volume":"11","author":"Volcheck","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.anai.2023.05.010_bib0058","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/ALN.0000000000000276","article-title":"Diagnostic value of histamine and tryptase concentrations in severe anaphylaxis with shock or cardiac arrest during anesthesia","volume":"121","author":"Laroche","year":"2014","journal-title":"Anesthesiology"},{"issue":"3","key":"10.1016\/j.anai.2023.05.010_bib0059","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/00000542-200309000-00007","article-title":"Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999-2000","volume":"99","author":"Mertes","year":"2003","journal-title":"Anesthesiology"},{"issue":"5","key":"10.1016\/j.anai.2023.05.010_bib0060","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.jaci.2013.06.015","article-title":"Anaphylaxis: clinical patterns, mediator release, and severity","volume":"132","author":"Brown","year":"2013","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.05.010_bib0061","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/bja\/80.1.26","article-title":"Mast cell tryptase in anaesthetic anaphylactoid reactions","volume":"80","author":"Fisher","year":"1998","journal-title":"Br J Anaesth"},{"issue":"4","key":"10.1016\/j.anai.2023.05.010_bib0062","doi-asserted-by":"crossref","first-page":"216","DOI":"10.18176\/jiaci.0236","article-title":"Practical guidelines for perioperative hypersensitivity reactions","volume":"28","author":"Laguna","year":"2018","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.05.010_bib0063","doi-asserted-by":"crossref","first-page":"e126","DOI":"10.1016\/j.bja.2019.03.018","article-title":"The use of drug provocation testing in the investigation of suspected immediate perioperative allergic reactions: current status","volume":"123","author":"Garvey","year":"2019","journal-title":"Br J Anaesth"},{"issue":"5","key":"10.1016\/j.anai.2023.05.010_bib0064","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1034\/j.1398-9995.2001.056005461.x","article-title":"False negative SPT after anaphylaxis","volume":"56","author":"Aalto-Korte","year":"2001","journal-title":"Allergy"},{"issue":"11","key":"10.1016\/j.anai.2023.05.010_bib0065","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1111\/j.1398-9995.2005.00963.x","article-title":"Diagnosis of Hymenoptera venom allergy","volume":"60","author":"Bil\u00f3","year":"2005","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.anai.2023.05.010_bib0066","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.jaip.2018.01.004","article-title":"In vitro diagnosis of immediate drug hypersensitivity during anesthesia: a review of the literature","volume":"6","author":"Ebo","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.anai.2023.05.010_bib0067","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.jaci.2020.08.015","article-title":"Persistent, refractory, and biphasic anaphylaxis: a multidisciplinary Delphi study","volume":"146","author":"Dribin","year":"2020","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.05.010_bib0068","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1398-9995.2007.01605.x","article-title":"Practical allergy (PRACTALL) report: risk assessment in anaphylaxis","volume":"63","author":"Simons","year":"2008","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.anai.2023.05.010_bib0069","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jaci.2009.04.004","article-title":"Management of food allergies in schools: a perspective for allergists","volume":"124","author":"Young","year":"2009","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2023.05.010_bib0070","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000354543","article-title":"World Allergy Organization Anaphylaxis Guidelines: 2013 update of the evidence base","volume":"162","author":"Simons","year":"2013","journal-title":"Int Arch Allergy Immunol"},{"issue":"3","key":"10.1016\/j.anai.2023.05.010_bib0071","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2011.01.038","article-title":"World Allergy Organization anaphylaxis guidelines: summary","volume":"127","author":"Simons","year":"2011","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2023.05.010_bib0072","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jaci.2020.01.017","article-title":"Anaphylaxis-a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis","volume":"145","author":"Shaker","year":"2020","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2023.05.010_bib0073","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jaip.2014.12.010","article-title":"Time of onset and predictors of biphasic anaphylactic reactions: a systematic review and meta-analysis","volume":"3","author":"Lee","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.anai.2023.05.010_bib0074","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1111\/all.14580","article-title":"Diagnosing, managing and preventing anaphylaxis: systematic review","volume":"76","author":"de Silva","year":"2021","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.anai.2023.05.010_bib0075","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13223-021-00511-y","article-title":"The pharmacokinetics of epinephrine\/adrenaline autoinjectors","volume":"17","author":"Dreborg","year":"2021","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.05.010_bib0076","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jaip.2014.06.007","article-title":"Epinephrine in anaphylaxis: higher risk of cardiovascular complications and overdose after administration of intravenous bolus epinephrine compared with intramuscular epinephrine","volume":"3","author":"Campbell","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.anai.2023.05.010_bib0077","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1136\/adc.86.4.236","article-title":"How dangerous is food allergy in childhood? The incidence of severe and fatal allergic reactions across the UK and Ireland","volume":"86","author":"Macdougall","year":"2002","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.anai.2023.05.010_bib0078","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/JAA.S123053","article-title":"Anaphylaxis across two Canadian pediatric centers: evaluating management disparities","volume":"10","author":"Lee","year":"2017","journal-title":"J Asthma Allergy"},{"issue":"5","key":"10.1016\/j.anai.2023.05.010_bib0079","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.anai.2015.07.019","article-title":"Anaphylaxis\u2013a practice parameter update 2015","volume":"115","author":"Lieberman","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.05.010_bib0080","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s13223-022-00736-5","article-title":"International recommendations on epinephrine auto-injector doses often differ from standard weight-based guidance: a review and clinical proposals","volume":"18","author":"Dreborg","year":"2022","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2023.05.010_bib0081","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.annemergmed.2015.07.011","article-title":"Lacerations and embedded needles caused by epinephrine autoinjector use in children","volume":"67","author":"Brown","year":"2016","journal-title":"Ann Emerg Med"},{"issue":"6","key":"10.1016\/j.anai.2023.05.010_bib0082","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.anai.2017.03.017","article-title":"Inadequacy of current pediatric epinephrine autoinjector needle length for use in infants and toddlers","volume":"118","author":"Kim","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"10.1016\/j.anai.2023.05.010_bib0083","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.anai.2018.02.028","article-title":"Epinephrine auto-injector needle lengths: can both subcutaneous and periosteal\/intraosseous injection be avoided?","volume":"120","author":"Dreborg","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"8","key":"10.1016\/j.anai.2023.05.010_bib0084","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1046\/j.1365-2222.2000.00864.x","article-title":"Lessons for management of anaphylaxis from a study of fatal reactions","volume":"30","author":"Pumphrey","year":"2000","journal-title":"Clin Exp Allergy"},{"issue":"1","key":"10.1016\/j.anai.2023.05.010_bib0085","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/cea.14055","article-title":"Pharmacokinetics of adrenaline autoinjectors","volume":"52","author":"Turner","year":"2022","journal-title":"Clin Exp Allergy"},{"issue":"6","key":"10.1016\/j.anai.2023.05.010_bib0086","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1016\/j.jaip.2018.02.026","article-title":"Epinephrine in severe allergic reactions: the European anaphylaxis register","volume":"6","author":"Grabenhenrich","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.anai.2023.05.010_bib0087","doi-asserted-by":"crossref","first-page":"372","DOI":"10.24953\/turkjped.2021.03.004","article-title":"Healthcare workers; knowledge level regarding anaphylaxis and usage of epinephrine auto-injectors","volume":"63","author":"Arga","year":"2021","journal-title":"Turk J Pediatr"},{"issue":"6","key":"10.1016\/j.anai.2023.05.010_bib0088","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1056\/NEJM199208063270603","article-title":"Fatal and near-fatal anaphylactic reactions to food in children and adolescents","volume":"327","author":"Sampson","year":"1992","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.anai.2023.05.010_bib0089","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000059406","article-title":"Epinephrine fails to hasten hemodynamic recovery in fully developed canine anaphylactic shock","volume":"128","author":"Bautista","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"issue":"suppl 24","key":"10.1016\/j.anai.2023.05.010_bib0090","article-title":"Derivation of a clinical decision rule to predict biphasic reactions in emergency department anaphylaxis patients","volume":"24","author":"Lee","year":"2017","journal-title":"Acad Emerg Med"},{"issue":"1","key":"10.1016\/j.anai.2023.05.010_bib0091","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.anai.2021.03.011","article-title":"Risk factors for fatal and nonfatal reactions to immunotherapy (2008-2018): postinjection monitoring and severe asthma","volume":"127","author":"Epstein","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"10.1016\/j.anai.2023.05.010_bib0092","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.jaip.2018.10.042","article-title":"Relationship between anaphylaxis and use of beta-blockers and angiotensin-converting enzyme inhibitors: a systematic review and meta-analysis of observational studies","volume":"7","author":"Tejedor-Alonso","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.anai.2023.05.010_bib0093","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jaci.2011.09.033","article-title":"Current practices among allergists on writing self-injectable epinephrine prescriptions for immunotherapy patients","volume":"129","author":"Gupta","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2023.05.010_bib0094","doi-asserted-by":"crossref","first-page":"AB8","DOI":"10.1016\/j.jaci.2019.12.852","article-title":"Allergist trends in epinephrine prescribing and usage patterns","volume":"145","author":"Greenhawt","year":"2020","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2023.05.010_bib0095","doi-asserted-by":"crossref","first-page":"258","DOI":"10.4236\/ijohns.2021.104024","article-title":"Current practices in Prescribing auto-injectable epinephrine during immunotherapy amongst otolaryngic allergists","volume":"10","author":"Haroun","year":"2021","journal-title":"Int J Otolaryngol Head Neck Surgery"},{"issue":"1 suppl","key":"10.1016\/j.anai.2023.05.010_bib0096","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2010.09.034","article-title":"Allergen immunotherapy: a practice parameter third update","volume":"127","author":"Cox","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2023.05.010_bib0097","first-page":"258","article-title":"Current Practices in Prescribing Auto-Injectable Epinephrine during Immunotherapy amongst Otolaryngic Allergists","volume":"10","author":"Haroun","year":"2021","journal-title":"Int J Otorhinolaryngol Head Neck Surg"},{"issue":"4","key":"10.1016\/j.anai.2023.05.010_bib0098","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/all.13317","article-title":"EAACI guidelines on allergen immunotherapy: allergic rhinoconjunctivitis","volume":"73","author":"Roberts","year":"2018","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.anai.2023.05.010_bib0099","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.jaci.2021.03.042","article-title":"Use of multiple epinephrine doses in anaphylaxis: a systematic review and meta-analysis","volume":"148","author":"Patel","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2023.05.010_bib0100","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/j.jaip.2018.01.019","article-title":"Value of a second dose of epinephrine during anaphylaxis: a patient\/caregiver survey","volume":"6","author":"Song","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.anai.2023.05.010_bib0101","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.jaip.2015.04.009","article-title":"Predictors of repeat epinephrine administration for emergency department patients with anaphylaxis","volume":"3","author":"Campbell","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.anai.2023.05.010_bib0102","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1016\/j.jaip.2021.01.007","article-title":"A cost-effectiveness analysis of epinephrine autoinjector risk stratification for patients with food allergy-one epinephrine autoinjector or two?","volume":"9","author":"Shaker","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.anai.2023.05.010_bib0103","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.5415\/apallergy.2019.9.e12","article-title":"Carrying rates of epinephrine devices in children with food-induced anaphylaxis","volume":"9","author":"Ratanaprug","year":"2019","journal-title":"Asia Pac Allergy"},{"issue":"3","key":"10.1016\/j.anai.2023.05.010_bib0104","doi-asserted-by":"crossref","DOI":"10.1136\/bmjoq-2021-001742","article-title":"Improving epinephrine autoinjector usability and carriage frequency among patients at risk of anaphylaxis: a quality improvement initiative","volume":"11","author":"Ziyar","year":"2022","journal-title":"BMJ Open Qual"},{"issue":"4","key":"10.1016\/j.anai.2023.05.010_bib0105","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.anai.2018.06.010","article-title":"Epinephrine auto-injector carriage and use practices among US children, adolescents, and adults","volume":"121","author":"Warren","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.05.010_bib0106","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13223-020-00418-0","article-title":"Hooked epinephrine auto-injector devices in children: four case reports with three different proposed mechanisms","volume":"16","author":"Goldman","year":"2020","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.05.010_bib0107","doi-asserted-by":"crossref","first-page":"e110","DOI":"10.1097\/MJT.0000000000000541","article-title":"Unintentional epinephrine auto-injector injuries: a national poison center observational study","volume":"26","author":"Anshien","year":"2019","journal-title":"Am J Ther"},{"issue":"5","key":"10.1016\/j.anai.2023.05.010_bib0108","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.surge.2020.01.005","article-title":"Adrenaline auto-injector injuries to digits; a systematic review and recommendations for emergency management","volume":"18","author":"Walsh","year":"2020","journal-title":"Surgeon"},{"issue":"1","key":"10.1016\/j.anai.2023.05.010_bib0109","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006312","article-title":"H1-antihistamines for the treatment of anaphylaxis with and without shock","volume":"2007","author":"Sheikh","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"10.1016\/j.anai.2023.05.010_bib0110","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/all.12437","article-title":"Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology","volume":"69","author":"Muraro","year":"2014","journal-title":"Allergy"},{"issue":"11","key":"10.1016\/j.anai.2023.05.010_bib0111","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1111\/j.1365-2222.2004.02106.x","article-title":"Constant infusion of epinephrine, but not bolus treatment, improves haemodynamic recovery in anaphylactic shock in dogs","volume":"34","author":"Mink","year":"2004","journal-title":"Clin Exp Allergy"},{"issue":"7","key":"10.1016\/j.anai.2023.05.010_bib0112","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1016\/j.jaip.2019.04.018","article-title":"Evaluation of prehospital management in a Canadian emergency department anaphylaxis cohort","volume":"7","author":"Gabrielli","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"9","key":"10.1016\/j.anai.2023.05.010_bib0113","first-page":"e29336","article-title":"Real world management of anaphylaxis versus the National Institute for Health and Clinical Excellence (NICE) guidelines","volume":"14","author":"Nasr","year":"2022","journal-title":"Cureus"},{"issue":"5","key":"10.1016\/j.anai.2023.05.010_bib0114","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.jaip.2017.05.022","article-title":"Do corticosteroids prevent biphasic anaphylaxis?","volume":"5","author":"Alqurashi","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.anai.2023.05.010_bib0115","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/all.12318","article-title":"Management of anaphylaxis: a systematic review","volume":"69","author":"Dhami","year":"2014","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.anai.2023.05.010_bib0116","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.anai.2013.11.010","article-title":"H2-antihistamines for the treatment of anaphylaxis with and without shock: a systematic review","volume":"112","author":"Nurmatov","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"10.1016\/j.anai.2023.05.010_bib0117","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000435","article-title":"Low-dose adrenaline, promethazine, and hydrocortisone in the prevention of acute adverse reactions to antivenom following snakebite: a randomised, double-blind, placebo-controlled trial","volume":"8","author":"de Silva","year":"2011","journal-title":"PLoS Med"},{"issue":"4","key":"10.1016\/j.anai.2023.05.010_bib0118","article-title":"Glucocorticoids for the treatment of anaphylaxis","volume":"2012","author":"Choo","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.anai.2023.05.010_bib0119","doi-asserted-by":"crossref","first-page":"344","DOI":"10.2500\/aap.2022.43.210108","article-title":"Accelerated\/rush allergen immunotherapy","volume":"43","author":"Greiwe","year":"2022","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.anai.2023.05.010_bib0120","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1748-5908-4-75","article-title":"Dual equipoise shared decision making: definitions for decision and behaviour support interventions","volume":"4","author":"Elwyn","year":"2009","journal-title":"Implement Sci"},{"issue":"4","key":"10.1016\/j.anai.2023.05.010_bib0121","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.jaip.2019.02.002","article-title":"Mast cell activation syndrome and mastocytosis: initial treatment options and long-term management","volume":"7","author":"Castells","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.anai.2023.05.010_bib0122","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2500\/aap.2021.42.210081","article-title":"Idiopathic anaphylaxis: diagnosis and management","volume":"42","author":"Burrows","year":"2021","journal-title":"Allergy Asthma Proc"},{"issue":"4","key":"10.1016\/j.anai.2023.05.010_bib0123","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S1081-1206(10)63322-4","article-title":"Idiopathic anaphylaxis: a series of 335 cases","volume":"77","author":"Ditto","year":"1996","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"10.1016\/j.anai.2023.05.010_bib0124","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0091-6749(97)70244-6","article-title":"Pediatric idiopathic anaphylaxis: experience with 22 patients","volume":"100","author":"Ditto","year":"1997","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"10.1016\/j.anai.2023.05.010_bib0125","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/cea.13402","article-title":"Idiopathic anaphylaxis","volume":"49","author":"Bilo","year":"2019","journal-title":"Clin Exp Allergy"},{"issue":"3","key":"10.1016\/j.anai.2023.05.010_bib0126","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.jaci.2020.11.005","article-title":"A randomized double-blind, placebo-controlled study of omalizumab for idiopathic anaphylaxis","volume":"147","author":"Carter","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2023.05.010_bib0127","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/ACI.0000000000000657","article-title":"Beta-blockers and angiotensin-converting enzyme inhibitors with sublingual immunotherapy: are risks related to individual product safety profile?","volume":"20","author":"Smith","year":"2020","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2023.05.010_bib0128","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.jaip.2017.12.020","article-title":"Patients taking beta-blockers do not require increased doses of epinephrine for anaphylaxis","volume":"6","author":"White","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.anai.2023.05.010_bib0129","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jaci.2005.06.019","article-title":"Beta-blockers and anaphylaxis: are the risks overstated?","volume":"116","author":"Miller","year":"2005","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2023.05.010_bib0130","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1016\/j.jaip.2019.10.020","article-title":"Risk for anaphylactic reaction from cardiac catheterization in patients receiving beta-adrenergic blockers or angiotensin-converting enzyme-inhibitors","volume":"8","author":"Smith","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"7","key":"10.1016\/j.anai.2023.05.010_bib0131","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1111\/all.14785","article-title":"Beta-blockers and ACE inhibitors are not a risk factor for severe systemic sting reactions and adverse events during venom immunotherapy","volume":"76","author":"Sturm","year":"2021","journal-title":"Allergy"},{"issue":"20","key":"10.1016\/j.anai.2023.05.010_bib0132","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1001\/2013.jamainternmed.34","article-title":"Comparative risk for angioedema associated with the use of drugs that target the renin-angiotensin-aldosterone system","volume":"172","author":"Toh","year":"2012","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1016\/j.anai.2023.05.010_bib0133","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jaci.2014.09.004","article-title":"Ramipril and metoprolol intake aggravate human and murine anaphylaxis: evidence for direct mast cell priming","volume":"135","author":"Nassiri","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"10.1016\/j.anai.2023.05.010_bib0134","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1111\/all.15318","article-title":"Risk factors for severe reactions in food allergy: rapid evidence review with meta-analysis","volume":"77","author":"Turner","year":"2022","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.anai.2023.05.010_bib0135","first-page":"977","article-title":"Should beta-blockers be given to patients with heart disease and peanut-induced anaphylaxis? A decision analysis","volume":"113","author":"TenBrook","year":"2004","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"10.1016\/j.anai.2023.05.010_bib0136","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203496","article-title":"A systematic review and meta-regression of the knowledge, practices, and training of restaurant and food service personnel toward food allergies and celiac disease","volume":"13","author":"Young","year":"2018","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.anai.2023.05.010_bib0137","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.4315\/0362-028X.JFP-16-085","article-title":"Food allergy knowledge and attitudes of restaurant managers and staff: an EHS-net study","volume":"79","author":"Radke","year":"2016","journal-title":"J Food Prot"},{"issue":"4","key":"10.1016\/j.anai.2023.05.010_bib0138","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0214625","article-title":"Food allergy knowledge, attitudes and their determinants among restaurant staff: a cross-sectional study","volume":"14","author":"Loerbroks","year":"2019","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.anai.2023.05.010_bib0139","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.jaci.2021.01.034","article-title":"Prevention and management of allergic reactions to food in child care centers and schools: practice guidelines","volume":"147","author":"Waserman","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"9250","key":"10.1016\/j.anai.2023.05.010_bib0140","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0140-6736(00)03543-1","article-title":"Long-term prospective observational study of patients with peanut and nut allergy after participation in a management plan","volume":"357","author":"Ewan","year":"2001","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.anai.2023.05.010_bib0141","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1365-2222.2005.02266.x","article-title":"Efficacy of a management plan based on severity assessment in longitudinal and case-controlled studies of 747 children with nut allergy: proposal for good practice","volume":"35","author":"Ewan","year":"2005","journal-title":"Clin Exp Allergy"},{"issue":"2","key":"10.1016\/j.anai.2023.05.010_bib0142","doi-asserted-by":"crossref","first-page":"AB211","DOI":"10.1016\/j.jaci.2014.12.1624","article-title":"School staff food allergy (FA) education increases epinephrine coverage and recognition of allergic reactions","volume":"135","author":"Kourosh","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2023.05.010_bib0143","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jaci.2008.05.015","article-title":"Good prognosis, clinical features, and circumstances of peanut and tree nut reactions in children treated by a specialist allergy center","volume":"122","author":"Clark","year":"2008","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"10.1016\/j.anai.2023.05.010_bib0144","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1034\/j.1398-9995.2001.00047.x","article-title":"Food anaphylaxis in schools: evaluation of the management plan and the efficiency of the emergency kit","volume":"56","author":"Moneret-Vautrin","year":"2001","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.anai.2023.05.010_bib0145","doi-asserted-by":"crossref","first-page":"AB288","DOI":"10.1016\/j.jaci.2013.12.1018","article-title":"Longitudinal effect of food allergy education on epinephrine availability in public schools","volume":"133","author":"Patel","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.05.010_bib0146","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jaip.2018.05.015","article-title":"Benefits of school nurse training sessions for food allergy and anaphylaxis management","volume":"7","author":"Tsuang","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.anai.2023.05.010_bib0147","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.jaip.2018.08.025","article-title":"The use of medical alert jewelry to communicate allergy information","volume":"7","author":"Le","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"9","key":"10.1016\/j.anai.2023.05.010_bib0148","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/anae.13958","article-title":"Medical identification or alert jewellery: an opportunity to save lives or an unreliable hindrance?","volume":"72","author":"Rahman","year":"2017","journal-title":"Anaesthesia"},{"key":"10.1016\/j.anai.2023.05.010_bib0149","article-title":"announces the FDA's acceptance of ARS Pharmaceuticals\u2019 NDA for neffy\u00ae (epinephrine nasal spray) for the treatment of allergic reactions (type I) including anaphylaxis","year":"2022","journal-title":"News release"},{"key":"10.1016\/j.anai.2023.05.010_bib0150","article-title":"ARS Pharmaceuticals announces results from EPI-04 clinical study of ARS-1 intranasal epinephrine spray in allergy patients with allergic rhinitis","year":"2019","journal-title":"News release"},{"issue":"2","key":"10.1016\/j.anai.2023.05.010_bib0151","doi-asserted-by":"crossref","first-page":"AB78","DOI":"10.1016\/j.jaci.2019.12.669","article-title":"Comparison of the pharmacokinetics and pharmacodynamics of epinephrine after intranasal (IN), intramuscular (IM) and subcutaneous (SC) administration in three landmark studies","volume":"145","author":"Lockey","year":"2020","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2023.05.010_bib0152","doi-asserted-by":"crossref","first-page":"AB77","DOI":"10.1016\/j.jaci.2019.12.668","article-title":"A phase 1, five-period, five-treatment, randomized crossover study of the pharmacokinetics (PK) and pharmacodynamics (PD) of epinephrine after administration of intranasal (IN) ARS-1 and intramuscular (IM) epinephrine to healthy volunteers","volume":"145","author":"Tanimoto","year":"2020","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2023.05.010_bib0153","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jaci.2009.03.050","article-title":"Anaphylaxis in the community: learning from the survivors","volume":"124","author":"Simons","year":"2009","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2023.05.010_bib0154","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jaci.2008.05.028","article-title":"Anaphylaxis management plans for the acute and long-term management of anaphylaxis: a systematic review","volume":"122","author":"Nurmatov","year":"2008","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2023.05.010_bib0155","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1258\/shorts.2010.010060","article-title":"Key components of anaphylaxis management plans: consensus findings from a national electronic Delphi study","volume":"1","author":"Worth","year":"2010","journal-title":"JRSM Short Rep"},{"issue":"5","key":"10.1016\/j.anai.2023.05.010_bib0156","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.jaip.2017.06.032","article-title":"Reviewing the content and design of anaphylaxis management plans published in English","volume":"5","author":"Mercer","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.anai.2023.05.010_bib0157","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2147\/JAA.S159400","article-title":"Underuse of epinephrine for the treatment of anaphylaxis: missed opportunities","volume":"11","author":"Prince","year":"2018","journal-title":"J Asthma Allergy"},{"issue":"5","key":"10.1016\/j.anai.2023.05.010_bib0158","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/ACI.0000000000000680","article-title":"Epinephrine in anaphylaxis: too little, too late","volume":"20","author":"Lieberman","year":"2020","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2023.05.010_bib0159","doi-asserted-by":"crossref","first-page":"100","DOI":"10.15586\/aei.v50i5.582","article-title":"Benefit of educational intervention on autoinjector technique for caregivers and paediatric patients with food allergies: a literature review","volume":"50","author":"Trujillo","year":"2022","journal-title":"Allergol Immunopathol (Madr)"},{"issue":"1","key":"10.1016\/j.anai.2023.05.010_bib0160","first-page":"14","article-title":"Effect of instruction on the ability to use a self-administered epinephrine injector","volume":"14","author":"Segal","year":"2012","journal-title":"Isr Med Assoc J"},{"issue":"2","key":"10.1016\/j.anai.2023.05.010_bib0161","doi-asserted-by":"crossref","first-page":"AB153","DOI":"10.1016\/j.jaci.2018.12.464","article-title":"Outcomes of simulated use of Epinephrine injection USP auto-injectors","volume":"143","author":"Peterson","year":"2019","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2023.05.010_bib0162","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000504365","article-title":"Is there an optimal training interval to improve the correct use of adrenaline auto-injectors?","volume":"181","author":"Sirin Kose","year":"2020","journal-title":"Int Arch Allergy Immunol"},{"issue":"3","key":"10.1016\/j.anai.2023.05.010_bib0163","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000477566","article-title":"Safety of adrenaline use in anaphylaxis: a multicentre register","volume":"173","author":"Cardona","year":"2017","journal-title":"Int Arch Allergy Immunol"},{"issue":"6","key":"10.1016\/j.anai.2023.05.010_bib0164","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1016\/j.jaip.2018.04.006","article-title":"Summary and simulation of reported adverse events from epinephrine autoinjectors and a review of the literature","volume":"6","author":"Shaker","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"8","key":"10.1016\/j.anai.2023.05.010_bib0165","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1111\/cea.12520","article-title":"Anaphylaxis and cardiovascular disease: therapeutic dilemmas","volume":"45","author":"Lieberman","year":"2015","journal-title":"Clin Exp Allergy"},{"issue":"1","key":"10.1016\/j.anai.2023.05.010_bib0166","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.anai.2018.06.035","article-title":"An economic evaluation of immediate vs non-immediate activation of emergency medical services after epinephrine use for peanut-induced anaphylaxis","volume":"122","author":"Shaker","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"10.1016\/j.anai.2023.05.010_bib0167","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.jaip.2020.04.022","article-title":"Acute at home management of anaphylaxis during the COVID-19 pandemic","volume":"8","author":"Casale","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"9","key":"10.1016\/j.anai.2023.05.010_bib0168","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1016\/j.jaip.2022.04.040","article-title":"Acute at-home management of anaphylaxis: 911: what is the emergency?","volume":"10","author":"Casale","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.anai.2023.05.010_bib0169","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jaci.2007.06.025","article-title":"Anaphylaxis in infants: can recognition and management be improved?","volume":"120","author":"Simons","year":"2007","journal-title":"J Allergy Clin Immunol"},{"issue":"2 Pt 1","key":"10.1016\/j.anai.2023.05.010_bib0170","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S0091-6749(99)70392-1","article-title":"Epidemiology of anaphylaxis in Olmsted County: a population-based study","volume":"104","author":"Yocum","year":"1999","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2023.05.010_bib0171","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3109\/02770906609106941","article-title":"Diagnosis and treatment of insect sensitivity","volume":"3","author":"Mueller","year":"1966","journal-title":"J Asthma Res"},{"issue":"10","key":"10.1016\/j.anai.2023.05.010_bib0172","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1111\/all.13820","article-title":"An EAACI position paper on the investigation of perioperative immediate hypersensitivity reactions","volume":"74","author":"Garvey","year":"2019","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.anai.2023.05.010_bib0173","first-page":"442","article-title":"Reducing the risk of anaphylaxis during anesthesia: 2011 updated guidelines for clinical practice","volume":"21","author":"Mertes","year":"2011","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2023.05.010_bib0174","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/BF02737644","article-title":"Anaphylaxis and anaphylactoid reactions. Classification and pathophysiology","volume":"17","author":"Ring","year":"1999","journal-title":"Clin Rev Allergy Immunol"},{"issue":"7","key":"10.1016\/j.anai.2023.05.010_bib0175","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s40629-021-00166-6","article-title":"Anaphylaxis: subjective symptom reports of patients with a special focus on \u201cnear-death\u201d experiences","volume":"30","author":"Ring","year":"2021","journal-title":"Allergo J Int"},{"issue":"9","key":"10.1016\/j.anai.2023.05.010_bib0176","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1111\/j.1365-2222.2005.02312.x","article-title":"Does severity of low-dose, double-blind, placebo-controlled food challenges reflect severity of allergic reactions to peanut in the community?","volume":"35","author":"Hourihane","year":"2005","journal-title":"Clin Exp Allergy"},{"issue":"1","key":"10.1016\/j.anai.2023.05.010_bib0177","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1016\/j.bja.2019.02.029","article-title":"Consensus clinical scoring for suspected perioperative immediate hypersensitivity reactions","volume":"123","author":"Hopkins","year":"2019","journal-title":"Br J Anaesth"},{"issue":"4","key":"10.1016\/j.anai.2023.05.010_bib0178","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.anai.2021.04.015","article-title":"A severity grading system of food-induced acute allergic reactions to avoid the delay of epinephrine administration","volume":"127","author":"Blazowski","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"10.1016\/j.anai.2023.05.010_bib0179","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1200435","article-title":"Oral immunotherapy for treatment of egg allergy in children","volume":"367","author":"Burks","year":"2012","journal-title":"N Engl J Med"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120623003368?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120623003368?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:31:18Z","timestamp":1761053478000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120623003368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":179,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S1081120623003368"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2023.05.010","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Knowledge gaps in the diagnosis and management of anaphylaxis","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2023.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}